In addition, we elaborate on studies that have led to approval of the first FcRn antagonists, the clinical progress and structural design of molecules in the pipeline, their position in the overall therapeutic landscape of autoimmunity, the design of next-generation antagonists as well as the use of this receptor-targeting principle for other therapeutic applications
It is contraindicated in patients with a personal or family history of certain thyroid cancers
FDA via DailyMed (Hospira)) [4] Stroppel L et al
POWERFUL ANTIOXODANT PROTECTION: The powerful antioxidant properties protect the body from free radicals, maintain cellular health, boost the immune system and are known to slow the aging process
About the Experts Ethan Lazarus, M.D., F.A.A.F.P
National Institutes of Health, 2015)